[HTML][HTML] The current best drug treatment for hypertensive heart failure with preserved ejection fraction
A Rist, K Sevre, K Wachtell, RB Devereux… - European journal of …, 2023 - Elsevier
More than 90% of patients developing heart failure (HF) have hypertension. The most
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
[HTML][HTML] The current best drug treatment for hypertensive heart failure with preserved ejection fraction
A Rist, K Sevre, K Wachtell, RB Devereux… - European Journal of …, 2024 - ejinme.com
More than 90% of patients developing heart failure (HF) have hypertension. The most
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
The current best drug treatment for hypertensive heart failure with preserved ejection fraction
A Rist, K Sevre, K Wachtell, RB Devereux… - European journal of … - pubmed.ncbi.nlm.nih.gov
More than 90% of patients developing heart failure (HF) have hypertension. The most
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
The current best drug treatment for hypertensive heart failure with preserved ejection fraction
A Rist, K Sevre, K Wachtell, RB Devereux… - European journal of …, 2024 - duo.uio.no
More than 90% of patients developing heart failure (HF) have hypertension. The most
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
The current best drug treatment for hypertensive heart failure with preserved ejection fraction.
A Rist, K Sevre, K Wachtell, RB Devereux… - European Journal of …, 2023 - europepmc.org
More than 90% of patients developing heart failure (HF) have hypertension. The most
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
The current best drug treatment for hypertensive heart failure with preserved ejection fraction
A Rist, K Sevre, K Wachtell, R Devereux… - EUROPEAN …, 2023 - boa.unimib.it
More than 90% of patients developing heart failure (HF) have hypertension. The most
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
[PDF][PDF] The current best drug treatment for hypertensive heart failure with preserved ejection fraction
A Rist, K Sevre, K Wachtell, RB Devereux… - European Journal of …, 2024 - serval.unil.ch
More than 90% of patients developing heart failure (HF) have hypertension. The most
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
[引用][C] The current best drug treatment for hypertensive heart failure with preserved ejection fraction
A Rist, K Sevre, K Wachtell, R Devereux… - European Journal of …, 2023 - hal.univ-lorraine.fr
The current best drug treatment for hypertensive heart failure with preserved ejection fraction -
Université de Lorraine Accéder directement au contenu Documentation FR Français (FR) …
Université de Lorraine Accéder directement au contenu Documentation FR Français (FR) …
[PDF][PDF] The current best drug treatment for hypertensive heart failure with preserved ejection fraction
A Rist, K Sevre, K Wachtell, RB Devereux… - European Journal of …, 2024 - serval.unil.ch
More than 90% of patients developing heart failure (HF) have hypertension. The most
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …